BIOMAT Database Logo BIOMAT Database Logo

Prothrombin conversion factor of dicumarol plasma. 1948

C A OWEN, and J L BOLLMAN

UI MeSH Term Description Entries
D010949 Plasma The residual portion of BLOOD that is left after removal of BLOOD CELLS by CENTRIFUGATION without prior BLOOD COAGULATION. Blood Plasma,Fresh Frozen Plasma,Blood Plasmas,Fresh Frozen Plasmas,Frozen Plasma, Fresh,Frozen Plasmas, Fresh,Plasma, Blood,Plasma, Fresh Frozen,Plasmas,Plasmas, Blood,Plasmas, Fresh Frozen
D011516 Prothrombin A plasma protein that is the inactive precursor of thrombin. It is converted to thrombin by a prothrombin activator complex consisting of factor Xa, factor V, phospholipid, and calcium ions. Deficiency of prothrombin leads to hypoprothrombinemia. Coagulation Factor II,Factor II,Blood Coagulation Factor II,Differentiation Reversal Factor,Factor II, Coagulation,Factor, Differentiation Reversal,II, Coagulation Factor
D001728 Dicumarol An oral anticoagulant that interferes with the metabolism of vitamin K. It is also used in biochemical experiments as an inhibitor of reductases. Bishydroxycoumarin,Dicoumarin,Dicoumarol
D006490 Hemostatics Agents acting to arrest the flow of blood. Absorbable hemostatics arrest bleeding either by the formation of an artificial clot or by providing a mechanical matrix that facilitates clotting when applied directly to the bleeding surface. These agents function more at the capillary level and are not effective at stemming arterial or venous bleeding under any significant intravascular pressure. Antihemorrhagic,Hemostatic,Antihemorrhagics

Related Publications

C A OWEN, and J L BOLLMAN
Dicumarol-induced prothrombin in bovine plasma.
January 1970, Acta chemica Scandinavica,
C A OWEN, and J L BOLLMAN
The relationship of plasma prothrombin concentration and the degradation rate of serum "prothrombin-converting factor" during dicumarol therapy.
April 1950, Blood,
C A OWEN, and J L BOLLMAN
Fate of dicumarol in man; relationship between prothrombin time and plasma levels of dicumarol.
July 1949, Bulletin of the New York Academy of Medicine,
C A OWEN, and J L BOLLMAN
Plasma prothrombin during treatment with Dicumarol. II. Demonstration of an abnormal prothrombin fraction.
January 1968, Scandinavian journal of clinical and laboratory investigation,
C A OWEN, and J L BOLLMAN
Plasma prothrombin during treatment with Dicumarol. I. Immunochemical determination of its concentration in plasma.
January 1968, Scandinavian journal of clinical and laboratory investigation,
C A OWEN, and J L BOLLMAN
The action of dicumarol in the human being on plasma prothrombin time and total prothrombin time.
July 1952, American heart journal,
C A OWEN, and J L BOLLMAN
EFFECTS of dicumarol on prothrombin levels.
September 1950, Hospital management,
C A OWEN, and J L BOLLMAN
The effect of phenylindanedione on plasma prothrombin and factor V levels and a comparison with the effect of dicumarol.
January 1950, Scandinavian journal of clinical and laboratory investigation,
C A OWEN, and J L BOLLMAN
Evolution of a prothrombin conversion accelerator in stored human plasma and prothrombin fractions.
November 1949, The American journal of physiology,
C A OWEN, and J L BOLLMAN
THE PROTHROMBIN TIME RESPONSE OF RABBITS TO DICUMAROL.
July 1964, Archives internationales de pharmacodynamie et de therapie,
Copied contents to your clipboard!